NSE · Equity shares · Biotechnology & Drugs

Biofil Chemicals & Pharmaceuticals Ltd BIOFILCHEM

NSE:INR 33.1316 Sept, 03:51 pm

BSE:INR 33.116 Sept, 03:51 pm

-0.52 · -1.55%

Advanced chart

Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.

Headline priceLast market snapshot16 Sept, 03:51 pm

Company fundamentalsStale · last-known data22 Jul, 01:23 pm

Research sections6 of 9 availableMissing source values remain unavailable, never zero-filled.

AI and Advanced

AI analysis and Advanced tools for BIOFILCHEM

Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.

AI analysisReview the complete evidence-led AI research workflow.Generate reportCreate a versioned report with entitlement and credit checks.Open AI ChatContinue a grounded conversation with the instrument in context.Advanced modulesOpen role- and entitlement-controlled portfolio and trading tools.

Snapshot

Price and key statistics

Reported and computed values remain separate; missing values are not converted to zero.

Previous closeINR 33.65

Day rangeINR 33 — INR 33.71

52-week rangeINR 25.6 — INR 47.5

Volume11,767

Market cap54.5

P/ENot available

Research path: Interpret Biofil Chemicals & Pharmaceuticals Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.

Validated OHLC

Interactive price chart

Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.

Open full workspace

BIOFILCHEMBiofil Chemicals & Pharmaceuticals Ltd1d · INR · NSE

Loading validated candles…

Resolution: 1d nativeOHLC validation passed0 candles loadedWheel: zoom · Shift+wheel: pan

Auditable calculations

Daily technical summary

Calculated from validated daily candles. Descriptive research only.

Calculating technicals…

Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.

Company reporting

Financial statements

IND AS · INR crore

Financial statement rows are unavailable.

Fundamentals

Valuation and ratios

Valuation data unavailable.

Risk and consensus

Source-qualified signals

Risk metrics

Overall RiskExtreme risk

Board Risk69.2

Analyst consensus

Analyst consensus unavailable.

Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.

Industry context

Peer comparison

Only peers present in the company profile payload are displayed.

Peer data unavailable in the company profile payload.

Shareholding

Ownership

Promoter: 46.79%
FII: 0.03%
Other: 53.21%

Company intelligence

Latest relevant news

Source, timestamp and external destination are shown. Provider relevance scores are not available.

Biofil Chemicals & Pharmaceuticals Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Fundamentals - Markets MojoMarket news · 3 Jun 2026, 2:01 am

Biofil Chemicals & Pharmaceuticals Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Fundamentals Markets Mojo

Biofil Chemicals FY26 net profit rises to ₹278.60 crore - scanx.tradeMarket news · 2 Jun 2026, 2:49 am

Biofil Chemicals FY26 net profit rises to ₹278.60 crore scanx.trade

Biofil Chemicals Q4 FY26: Exceptional Income Masks Operational Weakness - Markets MojoMarket news · 1 Jun 2026, 1:59 pm

Biofil Chemicals Q4 FY26: Exceptional Income Masks Operational Weakness Markets Mojo

Biofil Chemicals & Pharmaceuticals Ltd Upgraded to Sell on Improved Technicals and Valuation - Markets MojoMarket news · 1 Jun 2026, 11:46 am

Biofil Chemicals & Pharmaceuticals Ltd Upgraded to Sell on Improved Technicals and Valuation Markets Mojo

Biofil Chemicals & Pharmaceuticals standalone net profit rises 5.00% in the March 2026 quarter - Business StandardMarket news · 1 Jun 2026, 9:36 am

Biofil Chemicals & Pharmaceuticals standalone net profit rises 5.00% in the March 2026 quarter Business Standard

Biofil Chemicals FY26 Profit Jumps 399% To ₹2.79 Cr On Asset Sale - WhalesbookMarket news · 30 May 2026, 7:16 pm

Biofil Chemicals FY26 Profit Jumps 399% To ₹2.79 Cr On Asset Sale Whalesbook

Corporate actions

Events

2026-05-30board MeetingsAudited Results
2026-02-13board MeetingsQuarterly Results
2025-11-13board MeetingsQuarterly Results
2025-09-27annual General MeetingAGM
2025-09-15annual General MeetingPOM
2025-08-12board MeetingsQuarterly Results
2025-05-30board MeetingsAudited Results
2025-03-22annual General MeetingPOM

Rusaka Markets Community

Discussion and sentiment for Biofil Chemicals & Pharmaceuticals Ltd

Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.

Checking your Rusaka Markets account…

Company profile

Business information

What the company does

Not available

Company facts

Industry: Biotechnology & Drugs
Sector: Biotechnology & Drugs
NSE Code: BIOFILCHEM
BSE Code: 524396

Questions

Stock FAQ

What is the symbol and ISIN of Biofil Chemicals & Pharmaceuticals Ltd?

Biofil Chemicals & Pharmaceuticals Ltd has the symbol BIOFILCHEM and ISIN - INE829A01014.

What is the current price of Biofil Chemicals & Pharmaceuticals Ltd?

Biofil Chemicals & Pharmaceuticals Ltd is currently trading at INR 33.13.

What are the year high and year low of Biofil Chemicals & Pharmaceuticals Ltd?

Biofil Chemicals & Pharmaceuticals Ltd has a year high of INR 47.50 and a year low of INR 25.60.

What is the market capitalization of Biofil Chemicals & Pharmaceuticals Ltd?

Biofil Chemicals & Pharmaceuticals Ltd has a market capitalization of INR 54.50 crore.

What is the P/E ratio of Biofil Chemicals & Pharmaceuticals Ltd?

Biofil Chemicals & Pharmaceuticals Ltd has a P/E ratio of NA.

What is the dividend yield of Biofil Chemicals & Pharmaceuticals Ltd?

Biofil Chemicals & Pharmaceuticals Ltd has a dividend yield of NA.

How is the financial performance of Biofil Chemicals & Pharmaceuticals Ltd based on revenue, net income, and EPS?

Biofil Chemicals & Pharmaceuticals Ltd has revenue of NA, net income of NA, and EPS of NA.

What is the book value of Biofil Chemicals & Pharmaceuticals Ltd?

Biofil Chemicals & Pharmaceuticals Ltd has a book value of NA.

What is the debt-to-equity ratio of Biofil Chemicals & Pharmaceuticals Ltd?

Biofil Chemicals & Pharmaceuticals Ltd has a debt-to-equity ratio of NA.

What are the price-to-book and price-to-sales ratios of Biofil Chemicals & Pharmaceuticals Ltd?

Biofil Chemicals & Pharmaceuticals Ltd has a price-to-book ratio of NA and a price-to-sales ratio of NA.

Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.